Camobucol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCamobucol
Drug Alias NameCamobucolum卡莫布可AGIX-4207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAtherogenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAtherogenics Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksKEGG